New hope for older SMA patients with next-generation self-complementary AAV gene therapy

Hiroyuki Nakai1, Erika L Finanger2, Richard Jude Samulski3

  • 1Department of Molecular and Medical Genetics, Oregon Health & Science University School of Medicine, Portland, OR, USA; Department of Molecular Microbiology and Immunology, Oregon Health & Science University School of Medicine, Portland, OR, USA; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA.

Summary

No abstract available in PubMed .